Adaptive Biotechnologies (FRA:1HM) General and Admin. Expense : €76.4 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adaptive Biotechnologies General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Adaptive Biotechnologies's General and Admin. Expense for the three months ended in Mar. 2024 was €18.0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €76.4 Mil.

Adaptive Biotechnologies General and Admin. Expense Historical Data

The historical data trend for Adaptive Biotechnologies's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adaptive Biotechnologies General and Admin. Expense Chart

Adaptive Biotechnologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

General and Admin. Expense

Get a 7-Day Free Trial

27.30

40.72

65.93

83.57

76.97

Adaptive Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
General and Admin. Expense	Get a 7-Day Free Trial															19.46	20.59	18.81	19.01	18.03

Adaptive Biotechnologies General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €76.4 Mil.

Adaptive Biotechnologies General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Adaptive Biotechnologies's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Adaptive Biotechnologies (FRA:1HM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adaptive Biotechnologies Corp (FRA:1HM) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

ADPT:USA 1HM:Germany

Address

1165 Eastlake Avenue East, Seattle, WA, USA, 98109

Website

https://www.adaptivebiotech.com

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease ("MRD") in patients with multiple myeloma ("MM"), B cell acute lymphoblastic leukemia ("ALL") and chronic lymphocytic leukemia ("CLL") and is also available as a CLIA-validated laboratory developed test ("LDT") for patients with other lymphoid cancers, including diffuse large B-cell lymphoma ("DLBCL").

Adaptive Biotechnologies (FRA:1HM) Headlines

No Headlines